What we are studying
The purpose of the study is to compare two drug delivery devices for the treatment of COPD: nebulized therapies versus Dry Powered Inhalers (DPI). For the purpose of this study, medications delivered via nebulizer are: Brovana, Pulmicort and Atrovent, and medications delivered via DPI are: Spiriva and Advair. Both drug delivery devices and all medications are approved for use by the U.S. Food and Drug Administration (FDA).
A total of $100- $50 for completion of Visit 2 and $50 for completion of Visit 3